Biofluid Biopsies 2016
SELECTBIO is delighted to announce its highly focused International Conference Biofluid Biopsies which is scheduled to be held on May 27, 2016 in Sheraton Grand Bangalore Hotel at Brigade Gateway, Bengaluru, India.
Chamindie Punyadeera - Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology
Pravin D Potdar - Head, Jaslok Hospital & Research Centre
This single day event, focuses primarily on blood-based molecular biomarkers such as Circulating Tumor DNA (ctDNA) for developing biological fluid-based biopsies as well as Circulating Tumor Cells (CTCs) and Protein-based Circulating Biomarkers. This event is beneficial for the Scientists who are working or planning to work in the area of extracellular nucleic acids, extracellular vesicles, circulating cell free DNA, microRNA, Liquid biopsies etc.
This conference will provide scientists and researchers with most up-to-date information & emerging trends in the area of Biofluid Biopsies. Open discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the Circulating Biomarkers Landscape, especially in the Indian context.
This event is co-located with our International Conferences “Advanced Diagnostics 2016”, “Biomarkers India 2016”, “Microfluidics, Liquid Handling and Lab-on-a-Chip” and “Metabolomics India 2016”. Running alongside the conference will be an Exhibition covering the latest technological advances within these fields. Registered delegates will have unrestricted access to all the co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.
We look forward to welcoming you at the Biofluid Biopsies Conference and Exhibition and hope that the day will be both informative and enjoyable.
Call for Papers:
If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!
Oral Presentation Submission Deadline: 31 March 2016
Analysis of Somatic Mutations in ctDNA and CTCs
Circulating RNAs as a Potential Biomarker Class
Circulating Tumor Cells (CTCs) as Prognostic Biomarkers
Digital PCR (dPCR) Applications for Circulating Biomarker Interrogation
Emerging Technology Platforms for Developing Biofluid-based Biopsies
Extracellular Nucleic Acids based Technologies
Cell-Free DNA (cfDNA)
Extracellular RNA (exRNA)
Extracellular Vesicles (EVs) for Development of Biofluid-based Biopsies
Sponsorship and Exhibition Opportunities:
Maninderjit Singh, Exhibition Manager
Confirmed Speakers to date:
Winston Patrick Kuo, President, Predicine Holdings Ltd